The mechanism of S100A4 regulating Fibulin-5 expression to promote the proliferation and migration of PASMCs
Sleep and Breathing · 2026-05 · 30 (2)
DOI: 10.1007/s11325-026-03582-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, online erschienen am 02.04.2026. Verfasst von Bingzhu Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin, 300070,…. Hauptthemen laut MEDLINE: S100 Calcium-Binding Protein A4, Cell Proliferation, Cell Movement, Pulmonary Artery. Die Arbeit nennt 30 Literaturangaben. Gefördert von: The project of basic frontier research of the Science and Technology Bureau of Wuhan, Wuhan Science and Technology Innovation Bureau-Aurora Programme Project, Tianjin Key Medical Discipline(Specialty) Construction Project.
Abstract (Originalsprache)
PURPOSE: Pulmonary hypertension is a serious pulmonary vascular disease. During the course of development, pulmonary artery smooth muscle cells (PASMCs) exhibit hyperplasia, enhanced anti-apoptotic effect, cell deformation, and migration. S100A4 protein is a member of the S100 protein family, which can deform and migrate arterial smooth muscle cells. Pulmonary hypertension can increase S100A4 protein expression. However, the underlying mechanism by which S100A4 is involved in the progression of pulmonary hypertension remains unclear. METHODS: In this study, the effects of recombinant human S100A4 protein treatment on cell proliferation, migration, and Fibulin-5 expression, as well as the effects of Fibulin-5 interference on cell proliferation and migration, were evaluated in human PASMCs. Subsequently, the impact of Fibulin-5 interference on cell proliferation and migration following recombinant human S100A4 protein treatment was investigated. RESULTS: It was demonstrated that exogenous S100A4 upregulated Fibulin-5 expression, thereby promoted PASMC proliferation. Conversely, Fibulin-5 interference was found to reverse the effects of Re-S100A4. CONCLUSION: This study further complements and improves the mechanism network related to pulmonary hypertension, thereby demonstrating that S100A4 and Fibulin-5 may become a new target for clinical intervention in pulmonary hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin, 300070, China.
- Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Jianghan University, Wuhan, 430000, China.
- Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, 154 Anshan Road, Heping District, Tianjin, 300070, China. luckydonglixia@163.com.
Förderung
- The project of basic frontier research of the Science and Technology Bureau of Wuhan
- Wuhan Science and Technology Innovation Bureau-Aurora Programme Project
- Tianjin Key Medical Discipline(Specialty) Construction Project
Zitieren
APA
Hu, B., Chen, S., & Dong, L. (2026). The mechanism of S100A4 regulating Fibulin-5 expression to promote the proliferation and migration of PASMCs. Sleep and Breathing, 30(2). https://doi.org/10.1007/s11325-026-03582-6
Vancouver
Hu B, Chen S, Dong L. The mechanism of S100A4 regulating Fibulin-5 expression to promote the proliferation and migration of PASMCs. Sleep and Breathing. 2026;30(2). doi:10.1007/s11325-026-03582-6
BibTeX
@article{Hu2026,
author = {Hu, Bingzhu and Chen, Shi and Dong, Lixia},
title = {The mechanism of S100A4 regulating Fibulin-5 expression to promote the proliferation and migration of PASMCs},
journal = {Sleep and Breathing},
year = {2026},
volume = {30},
number = {2},
doi = {10.1007/s11325-026-03582-6}
}
EUVIMED